These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 15643459)

  • 1. [Cyclic GMP as a biomarker for cardiovascular disease and cancer].
    Ulvestad L; Sager G
    Tidsskr Nor Laegeforen; 2005 Jan; 125(1):27-8. PubMed ID: 15643459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urinary cyclic GMP after treatment of gynecological cancer. A prognostic marker of clinical outcome.
    Orbo A; Hanevik M; Jaeger R; Van Heusden S; Sager G
    Anticancer Res; 2007; 27(4C):2591-6. PubMed ID: 17695420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated plasma and urinary guanosine 3':5'-monophosphate and increased production rate in patients with neoplastic diseases.
    Chawla RK; Shlaer SM; Lawson DH; Murray TG; Schmidt F; Shoji M; Nixon DW; Richmond A; Rudman D
    Cancer Res; 1980 Nov; 40(11):3915-20. PubMed ID: 6258769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cyclic GMP (cGMP)].
    Okuya S
    Nihon Rinsho; 2005 Aug; 63 Suppl 8():615-7. PubMed ID: 16149592
    [No Abstract]   [Full Text] [Related]  

  • 5. Guanosine 3', 5'-cyclic monophosphate level in plasma of patients with cancer and various diseases.
    Miyagi Y
    Bull Tokyo Med Dent Univ; 1979 Jun; 26(2):81-4. PubMed ID: 221127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP) levels in cancer tissue, plasma and urine of esophageal cancer patients].
    Zhao CY
    Zhonghua Zhong Liu Za Zhi; 1985 May; 7(3):175-7. PubMed ID: 2990838
    [No Abstract]   [Full Text] [Related]  

  • 7. Plasma cyclic nucleotide levels in monitoring acute leukemia patients.
    Peracchi M; Bamonti-Catena F; Lombardi L; Toschi V; Bareggi B; Cortelezzi A; Maiolo AT; Polli EE
    Cancer Detect Prev; 1985; 8(1-2):291-5. PubMed ID: 2998618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does circulating BNP normalize after heart transplantation in patients with normal hemodynamic and right and left heart functions?
    Talha S; Di Marco P; Doutreleau S; Rouyer O; Piquard F; Geny B
    Clin Transplant; 2008; 22(5):542-8. PubMed ID: 18394002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between systemic nitric oxide metabolites and cyclic GMP in healthy male volunteers.
    Metzger IF; Sertorio JT; Tanus-Santos JE
    Acta Physiol (Oxf); 2006 Oct; 188(2):123-7. PubMed ID: 16948799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical significance of urinary cyclic guanosine monophosphate in diagnosis of heart failure.
    Jakob G; Mair J; Vorderwinkler KP; Judmaier G; König P; Zwierzina H; Pichler M; Puschendorf B
    Clin Chem; 1994 Jan; 40(1):96-100. PubMed ID: 8287551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of varying continuous propofol infusions on plasma cyclic guanosine 3',5'-monophosphate concentrations in anesthetized children.
    Engelhardt T; Chan MK; McCheyne AJ; Karsli C; Luginbuehl I; Bissonnette B
    Anesth Analg; 2007 Sep; 105(3):616-9. PubMed ID: 17717213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth-differentiation factor-15 in heart failure.
    Kempf T; Wollert KC
    Heart Fail Clin; 2009 Oct; 5(4):537-47. PubMed ID: 19631178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma- and urine concentrations of nitrite/nitrate and cyclic Guanosinemonophosphate in intrauterine growth restricted and preeclamptic pregnancies.
    Schiessl B; Strasburger C; Bidlingmaier M; Mylonas I; Jeschke U; Kainer F; Friese K
    Arch Gynecol Obstet; 2006 Jun; 274(3):150-4. PubMed ID: 16532320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short-term dehydroepiandrosterone treatment increases platelet cGMP production in elderly male subjects.
    Martina V; Benso A; Gigliardi VR; Masha A; Origlia C; Granata R; Ghigo E
    Clin Endocrinol (Oxf); 2006 Mar; 64(3):260-4. PubMed ID: 16487434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urinary excretion of cyclic guanosine 3'.5'-monophosphate in children with malignant tumours.
    Puschendorf B; Grunicke H; Jentsch J; Berger H
    J Clin Chem Clin Biochem; 1981 Sep; 19(9):979-81. PubMed ID: 6270232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclic GMP release by acute enhanced external counterpulsation.
    Levenson J; Pernollet MG; Iliou MC; Devynck MA; Simon A
    Am J Hypertens; 2006 Aug; 19(8):867-72. PubMed ID: 16876689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phosphodiesterase 5 inhibitors: are they cardioprotective?
    Reffelmann T; Kloner RA
    Cardiovasc Res; 2009 Jul; 83(2):204-12. PubMed ID: 19474180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Uncovering early markers of cardiac disease by proteomics: avoiding (heart) failure!
    Gramolini AO; Emili A
    Expert Rev Proteomics; 2005 Oct; 2(5):631-4. PubMed ID: 16209642
    [No Abstract]   [Full Text] [Related]  

  • 19. [Natriuretic peptides--new diagnostic markers in heart disease].
    Angermann CE; Ertl G
    Herz; 2004 Sep; 29(6):609-17. PubMed ID: 15912436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heart failure reduces both the effects and interaction between cyclic GMP and cyclic AMP.
    Moalem J; Weiss HR; Davidov T; Rodriguez R; Molino B; Lazar MJ; Scholz PM
    J Surg Res; 2006 Aug; 134(2):300-6. PubMed ID: 16545395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.